Axim Biotechnologies Inc (AXIM) Return on Investment ROI from the second quarter of 2024 to second quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Axim Biotechnologies Inc   (AXIM)


Axim Biotechnologies Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Axim Biotechnologies Inc's ROI in the second quarter of 2024?
Axim Biotechnologies Inc recorded a cumulative net loss of $-4 million during 12 months ending in the second quarter of 2024, resulting in a negative return on investment (ROI) of -550.01%.

Within the Healthcare sector 922 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2024 quarter, so far to 4746, from total ROI ranking in the first quarter of 2024 at 4815.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Investment Change TTM -100 % -100 % -100 % -0.87 % -0.87 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -4 -2 10 0 -4
Return On Investment (TTM) - - -666.11 % - -
AXIM's Overall Ranking # 4746 # 4815 # 5538 # 2730 # 2793
Seq. Investment Change TTM -8.62 % -31.99 % -100 % -0 % -0 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -4 -6 -8 -7 -9

AXIM Company Profile >> Back to AXIM Roi Comparisons >> See Annual AXIM Return On Investment



Return On Investment AXIM's Ranking
Within: No.
Industry # 446
Sector # 923
Overall # 4746

Return On Investment Statistics
High Average Low
-0 %
-179.4 %
-1032.26 %
  (Mar 31 2013)







Financial Statements
Axim Biotechnologies Inc's II. Quarter Investments $ -4 Millions AXIM's Balance sheet
Axim Biotechnologies Inc's II. Quarter Income $ -2 Millions Quarterly AXIM's Income Statement
AXIM's Income by Division See AXIM's Income by Division


AXIM Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions -2 1 3 10 -2
Y / Y Investment Growth - -70.12 % -72.07 % - -
Net Income in Millions -8 -6 -16 -6 -6
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -761.77 % -584.6 % -65.29 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AXIM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AXIM's Competitors
Subscribers only: Roi for Axim Biotechnologies Inc's Suppliers
Subscribers only: Return On Investment for AXIM's Customers

Other Ratios
AXIM's Roa AXIM's Inventory Turnover Ratio AXIM's Growth Rates AXIM's Dividend Statistics
AXIM's Profitability Ratios AXIM's Asset Turnover Ratio AXIM's Dividend Growth
AXIM's Roe AXIM's Valuation Ratios AXIM's Financial Strength Ratios AXIM's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.